SSY Group Announces 95 Product Varieties Included in China's 2026 National Essential Medicines List

Stock News07-10

An announcement has been made by SSY GROUP (02005) regarding the inclusion of its products in a key national pharmaceutical catalog.

The company confirmed that a total of 95 product varieties, covering 141 specific specifications, have been incorporated into China's National Essential Medicines List for 2026.

This inclusion comprises 32 newly added varieties, which account for 37 specifications. The newly listed products include a range of medications such as Glucose and Sodium Chloride Injection, Levofloxacin Lactate and Sodium Chloride Injection, Sodium Bicarbonate Injection, Fluconazole Tablets, Gliclazide Tablets, and a variety of other injectable solutions, oral liquids, tablets, and dry suspensions.

The updated National Essential Medicines List is scheduled to take effect from September 1, 2026.

The company anticipates that this development will have a positive impact on its future growth and business expansion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1111172207?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 12:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111172207","market":"sh","top_or_hot":-1,"title":"SSY Group Announces 95 Product Varieties Included in China's 2026 National Essential Medicines List","media":"Stock News","content":"<p>An announcement has been made by <b>SSY GROUP</b> (<b>02005</b>) regarding the inclusion of its products in a key national pharmaceutical catalog.<br><br>The company confirmed that a total of 95 product varieties, covering 141 specific specifications, have been incorporated into China's National Essential Medicines List for 2026.<br><br>This inclusion comprises 32 newly added varieties, which account for 37 specifications. The newly listed products include a range of medications such as Glucose and Sodium Chloride Injection, Levofloxacin Lactate and Sodium Chloride Injection, Sodium Bicarbonate Injection, Fluconazole Tablets, Gliclazide Tablets, and a variety of other injectable solutions, oral liquids, tablets, and dry suspensions.<br><br>The updated National Essential Medicines List is scheduled to take effect from September 1, 2026.<br><br>The company anticipates that this development will have a positive impact on its future growth and business expansion.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SSY Group Announces 95 Product Varieties Included in China's 2026 National Essential Medicines List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSSY Group Announces 95 Product Varieties Included in China's 2026 National Essential Medicines List\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-10 12:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>An announcement has been made by <b>SSY GROUP</b> (<b>02005</b>) regarding the inclusion of its products in a key national pharmaceutical catalog.<br><br>The company confirmed that a total of 95 product varieties, covering 141 specific specifications, have been incorporated into China's National Essential Medicines List for 2026.<br><br>This inclusion comprises 32 newly added varieties, which account for 37 specifications. The newly listed products include a range of medications such as Glucose and Sodium Chloride Injection, Levofloxacin Lactate and Sodium Chloride Injection, Sodium Bicarbonate Injection, Fluconazole Tablets, Gliclazide Tablets, and a variety of other injectable solutions, oral liquids, tablets, and dry suspensions.<br><br>The updated National Essential Medicines List is scheduled to take effect from September 1, 2026.<br><br>The company anticipates that this development will have a positive impact on its future growth and business expansion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2460026573.USD","symbol_name":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","start_time":0,"source_url":"","article_id":"1111172207","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111172207","pubTimestamp":1783657582,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"An announcement has been made by SSY GROUP (02005) regarding the inclusion of its products in a key national pharmaceutical catalog.The company confirmed that a total of 95 product varieties,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","02005":"石四药集团","BK1191":"制药"},"translate_title":"SSY集团公布95个品种纳入中国2026年国家基本药物目录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02005":1},"content_text":"An announcement has been made by SSY GROUP (02005) regarding the inclusion of its products in a key national pharmaceutical catalog.The company confirmed that a total of 95 product varieties, covering 141 specific specifications, have been incorporated into China's National Essential Medicines List for 2026.This inclusion comprises 32 newly added varieties, which account for 37 specifications. The newly listed products include a range of medications such as Glucose and Sodium Chloride Injection, Levofloxacin Lactate and Sodium Chloride Injection, Sodium Bicarbonate Injection, Fluconazole Tablets, Gliclazide Tablets, and a variety of other injectable solutions, oral liquids, tablets, and dry suspensions.The updated National Essential Medicines List is scheduled to take effect from September 1, 2026.The company anticipates that this development will have a positive impact on its future growth and business expansion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1111172207","isCrawlerRequest":true}